Dexell - Model VUR - Injectable Implant for the Treatment of Vesicoureteral Reflux
Vesicoureteral reflux (VUR) is the retrograde passage of urine from the bladder into the upper urinary tract. It is the most common urological diagnosis in children, occuring in approximately 1 % of newborns and as high as 30 to 45% in children with UTI. Additionally, there is a high association between VUR, UTI, hypertension and renal damage.
-
Most popular related searches
Products Details
Treatment Options
Conventional Low Dose Antibiotic Therapy
-
Extended treatment time
-
Patient/parent non-compliance
-
Risk of antibiotic resistance
- Break through UTI
Surgical Ureter Reimplantation
- lnvasive
-
Reimplantation of ureter into bladder
-
High success rate
Endoscopic Dextranomer/Hyaluronic Acid Injection
-
Surgical injection of dextranomer/hyaluronic acid
-
Minimally invasive
- lmmediate correction of VUR
-
High success rate
Specifications
- Non Immunogenic
- Biocompatible
- Non allergic
- Biodegradable by time
- Long lasting
- No migration
- No rigid
Applications
DEXELL ® is suitable to be used with a cystoscopic injection needle in all injection methods e.g. STING and HIT.
Customer reviews
No reviews were found for Dexell - Model VUR - Injectable Implant for the Treatment of Vesicoureteral Reflux. Be the first to review!